59
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Pretreatment Neutrophil-to-Eosinophil Ratio with Clinical Outcomes in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab

ORCID Icon, , , , , & show all
Pages 3293-3302 | Received 18 Jul 2022, Accepted 13 Oct 2022, Published online: 27 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.